| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulatory subunit binding | 4.01e-05 | 14 | 98 | 3 | GO:0036312 | |
| GeneOntologyMolecularFunction | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity | 7.13e-05 | 3 | 98 | 2 | GO:0008109 | |
| GeneOntologyCellularComponent | anaphase-promoting complex | 1.60e-04 | 23 | 97 | 3 | GO:0005680 | |
| Domain | Nck-associated_protein-1 | 2.73e-05 | 2 | 98 | 2 | IPR019137 | |
| Domain | Nckap1 | 2.73e-05 | 2 | 98 | 2 | PF09735 | |
| Domain | TPR | 6.05e-05 | 129 | 98 | 6 | SM00028 | |
| Domain | TPR_repeat | 7.17e-05 | 133 | 98 | 6 | IPR019734 | |
| Domain | PI3K_P85_iSH2 | 8.15e-05 | 3 | 98 | 2 | IPR032498 | |
| Domain | PI3K_P85_iSH2 | 8.15e-05 | 3 | 98 | 2 | PF16454 | |
| Domain | TPR_2 | 1.36e-04 | 50 | 98 | 4 | PF07719 | |
| Domain | TPR_2 | 1.36e-04 | 50 | 98 | 4 | IPR013105 | |
| Domain | TPR-contain_dom | 1.39e-04 | 150 | 98 | 6 | IPR013026 | |
| Domain | - | 1.62e-04 | 4 | 98 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 1.62e-04 | 4 | 98 | 2 | PS51139 | |
| Domain | GTF2I | 1.62e-04 | 4 | 98 | 2 | PF02946 | |
| Domain | GTF2I | 1.62e-04 | 4 | 98 | 2 | IPR004212 | |
| Domain | SH3_1 | 2.26e-04 | 164 | 98 | 6 | PF00018 | |
| Domain | TPR-like_helical_dom | 2.27e-04 | 233 | 98 | 7 | IPR011990 | |
| Domain | TPR_REGION | 2.34e-04 | 165 | 98 | 6 | PS50293 | |
| Domain | TPR | 2.34e-04 | 165 | 98 | 6 | PS50005 | |
| Domain | PI3kinase_P85 | 2.70e-04 | 5 | 98 | 2 | IPR001720 | |
| Domain | CLTH | 4.03e-04 | 6 | 98 | 2 | PF10607 | |
| Domain | CRA | 4.03e-04 | 6 | 98 | 2 | SM00757 | |
| Domain | CTLH/CRA | 4.03e-04 | 6 | 98 | 2 | IPR024964 | |
| Domain | CRA_dom | 4.03e-04 | 6 | 98 | 2 | IPR013144 | |
| Domain | Glyco_trans_14 | 7.48e-04 | 8 | 98 | 2 | IPR003406 | |
| Domain | Branch | 7.48e-04 | 8 | 98 | 2 | PF02485 | |
| Domain | - | 7.78e-04 | 207 | 98 | 6 | 1.25.40.10 | |
| Domain | CTLH | 9.58e-04 | 9 | 98 | 2 | SM00668 | |
| Domain | LisH | 9.58e-04 | 9 | 98 | 2 | PF08513 | |
| Domain | SH3 | 9.71e-04 | 216 | 98 | 6 | SM00326 | |
| Domain | SH3 | 9.71e-04 | 216 | 98 | 6 | PS50002 | |
| Domain | SH3_domain | 1.07e-03 | 220 | 98 | 6 | IPR001452 | |
| Domain | CTLH_C | 1.19e-03 | 10 | 98 | 2 | IPR006595 | |
| Domain | CTLH | 1.19e-03 | 10 | 98 | 2 | PS50897 | |
| Domain | - | 1.74e-03 | 12 | 98 | 2 | 3.40.50.1010 | |
| Domain | Septin | 2.05e-03 | 13 | 98 | 2 | PF00735 | |
| Domain | G_SEPTIN_dom | 2.05e-03 | 13 | 98 | 2 | IPR030379 | |
| Domain | G_SEPTIN | 2.05e-03 | 13 | 98 | 2 | PS51719 | |
| Domain | PIN_domain-like | 2.38e-03 | 14 | 98 | 2 | IPR029060 | |
| Domain | Septin | 2.38e-03 | 14 | 98 | 2 | IPR016491 | |
| Domain | TPR_8 | 2.71e-03 | 53 | 98 | 3 | PF13181 | |
| Domain | ALPHA_CA_2 | 3.52e-03 | 17 | 98 | 2 | PS51144 | |
| Domain | Carb_anhydrase | 3.52e-03 | 17 | 98 | 2 | PF00194 | |
| Domain | Carb_anhydrase | 3.52e-03 | 17 | 98 | 2 | SM01057 | |
| Domain | - | 3.52e-03 | 17 | 98 | 2 | 3.10.200.10 | |
| Domain | Carbonic_anhydrase_a | 3.52e-03 | 17 | 98 | 2 | IPR001148 | |
| Domain | RhoGAP | 4.23e-03 | 62 | 98 | 3 | SM00324 | |
| Domain | RhoGAP | 4.43e-03 | 63 | 98 | 3 | PF00620 | |
| Domain | RHOGAP | 4.63e-03 | 64 | 98 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 4.63e-03 | 64 | 98 | 3 | IPR000198 | |
| Domain | - | 4.63e-03 | 64 | 98 | 3 | 1.10.555.10 | |
| Pathway | REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX | 4.04e-05 | 81 | 67 | 5 | MM15360 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 4.55e-05 | 42 | 67 | 4 | M41828 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 5.00e-05 | 43 | 67 | 4 | MM15679 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 5.10e-05 | 85 | 67 | 5 | M3578 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_ANAPHASE | 5.50e-05 | 16 | 67 | 3 | M47871 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING | 5.50e-05 | 16 | 67 | 3 | M47476 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 5.70e-05 | 87 | 67 | 5 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 6.02e-05 | 88 | 67 | 5 | M41810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DISASSEMBLY_OF_MCC | 6.65e-05 | 17 | 67 | 3 | M47888 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 6.70e-05 | 90 | 67 | 5 | MM15371 | |
| Pathway | REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE | 7.45e-05 | 92 | 67 | 5 | M27666 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 7.84e-05 | 93 | 67 | 5 | MM15609 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 8.25e-05 | 94 | 67 | 5 | M41818 | |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | 9.58e-05 | 97 | 67 | 5 | MM15369 | |
| Pathway | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | 1.10e-04 | 20 | 67 | 3 | MM14688 | |
| Pathway | REACTOME_PHOSPHORYLATION_OF_THE_APC_C | 1.10e-04 | 20 | 67 | 3 | MM14690 | |
| Pathway | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | 1.10e-04 | 20 | 67 | 3 | M1044 | |
| Pathway | REACTOME_PHOSPHORYLATION_OF_THE_APC_C | 1.10e-04 | 20 | 67 | 3 | M1050 | |
| Pathway | REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS | 1.10e-04 | 20 | 67 | 3 | M39015 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.27e-04 | 103 | 67 | 5 | MM14752 | |
| Pathway | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | 1.28e-04 | 21 | 67 | 3 | M489 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING | 1.28e-04 | 21 | 67 | 3 | M47583 | |
| Pathway | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | 1.28e-04 | 21 | 67 | 3 | MM14560 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.46e-04 | 106 | 67 | 5 | M27077 | |
| Pathway | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B | 1.93e-04 | 24 | 67 | 3 | MM14675 | |
| Pathway | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B | 1.93e-04 | 24 | 67 | 3 | M1039 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 2.05e-04 | 114 | 67 | 5 | MM14814 | |
| Pathway | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | 2.47e-04 | 26 | 67 | 3 | MM14697 | |
| Pathway | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | 2.47e-04 | 26 | 67 | 3 | M1079 | |
| Pathway | REACTOME_SYNTHESIS_OF_DNA | 2.71e-04 | 121 | 67 | 5 | M5224 | |
| Pathway | REACTOME_DNA_REPLICATION | 3.15e-04 | 125 | 67 | 5 | MM15380 | |
| Pathway | REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION | 3.30e-04 | 6 | 67 | 2 | M27492 | |
| Pathway | REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION | 3.30e-04 | 6 | 67 | 2 | MM15220 | |
| Pathway | REACTOME_DAP12_SIGNALING | 3.43e-04 | 29 | 67 | 3 | M27171 | |
| Pathway | REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6 | 3.56e-04 | 71 | 67 | 4 | MM15370 | |
| Pathway | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | 4.18e-04 | 74 | 67 | 4 | MM14678 | |
| Pathway | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | 4.18e-04 | 74 | 67 | 4 | M1030 | |
| Pathway | REACTOME_DAP12_SIGNALING | 4.19e-04 | 31 | 67 | 3 | MM14886 | |
| Pathway | REACTOME_SIGNALING_BY_LTK_IN_CANCER | 4.60e-04 | 7 | 67 | 2 | M48255 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 4.61e-04 | 32 | 67 | 3 | M39445 | |
| Pathway | REACTOME_ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | 4.86e-04 | 77 | 67 | 4 | MM14692 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 5.53e-04 | 34 | 67 | 3 | MM15265 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 5.84e-04 | 143 | 67 | 5 | M27107 | |
| Pathway | REACTOME_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE | 6.02e-04 | 35 | 67 | 3 | MM14689 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HYDROLYSIS_OF_SPHINGOMYELIN | 6.12e-04 | 8 | 67 | 2 | M47611 | |
| Pathway | REACTOME_PI3K_AKT_ACTIVATION | 6.12e-04 | 8 | 67 | 2 | MM14776 | |
| Pathway | REACTOME_S_PHASE | 6.41e-04 | 146 | 67 | 5 | MM15378 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 6.46e-04 | 83 | 67 | 4 | M47961 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 6.55e-04 | 36 | 67 | 3 | M27549 | |
| Pathway | PID_FAS_PATHWAY | 7.69e-04 | 38 | 67 | 3 | M94 | |
| Pathway | REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE | 7.69e-04 | 38 | 67 | 3 | M39005 | |
| Pathway | REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS | 7.71e-04 | 87 | 67 | 4 | MM14677 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDL_PD1_SHP_PI3K_SIGNALING_PATHWAY | 7.84e-04 | 9 | 67 | 2 | M47757 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 7.84e-04 | 9 | 67 | 2 | M47972 | |
| Pathway | REACTOME_PI3K_AKT_ACTIVATION | 7.84e-04 | 9 | 67 | 2 | M714 | |
| Pathway | REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS | 8.05e-04 | 88 | 67 | 4 | M29582 | |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | 8.30e-04 | 39 | 67 | 3 | MM14900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 8.40e-04 | 89 | 67 | 4 | M47963 | |
| Pathway | WP_IL5_SIGNALING | 8.94e-04 | 40 | 67 | 3 | M39392 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 8.94e-04 | 40 | 67 | 3 | M39695 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | NCKAP1 PTPN13 BAIAP2L1 PIK3R1 PIK3R2 BTK STIP1 ZW10 ARHGAP8 NCKAP1L | 9.21e-04 | 649 | 67 | 10 | MM15690 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | 9.42e-04 | 159 | 67 | 5 | M27665 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 9.61e-04 | 41 | 67 | 3 | M29748 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 9.61e-04 | 41 | 67 | 3 | MM14505 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 9.61e-04 | 41 | 67 | 3 | MM15630 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 1.03e-03 | 42 | 67 | 3 | M41826 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 1.03e-03 | 42 | 67 | 3 | M41821 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 1.03e-03 | 42 | 67 | 3 | MM15677 | |
| Pathway | REACTOME_S_PHASE | 1.05e-03 | 163 | 67 | 5 | M3158 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.08e-03 | 439 | 67 | 8 | MM15595 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 1.11e-03 | 43 | 67 | 3 | M41827 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 1.18e-03 | 44 | 67 | 3 | M175 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 1.18e-03 | 44 | 67 | 3 | MM15678 | |
| Pathway | REACTOME_SIGNALING_BY_LTK | 1.19e-03 | 11 | 67 | 2 | MM17235 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 1.27e-03 | 450 | 67 | 8 | M27078 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.35e-03 | 46 | 67 | 3 | M27151 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 1.35e-03 | 46 | 67 | 3 | MM15837 | |
| Pathway | REACTOME_SIGNALING_BY_LTK | 1.42e-03 | 12 | 67 | 2 | M48256 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 1.42e-03 | 12 | 67 | 2 | M29851 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 1.43e-03 | 47 | 67 | 3 | MM14885 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.44e-03 | 175 | 67 | 5 | MM15599 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 1.52e-03 | 48 | 67 | 3 | M26916 | |
| Pathway | PID_PI3KCI_PATHWAY | 1.52e-03 | 48 | 67 | 3 | M141 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 1.52e-03 | 48 | 67 | 3 | MM15441 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 1.71e-03 | 50 | 67 | 3 | MM14641 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.79e-03 | 271 | 67 | 6 | MM15388 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.80e-03 | 184 | 67 | 5 | M41809 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.91e-03 | 111 | 67 | 4 | M27673 | |
| Pathway | REACTOME_DNA_REPLICATION | 1.93e-03 | 187 | 67 | 5 | M1017 | |
| Pathway | WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE | 1.95e-03 | 14 | 67 | 2 | M39840 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | NCKAP1 PTPN13 BAIAP2L1 PIK3R1 PIK3R2 BTK STIP1 ZW10 ARHGAP8 NCKAP1L | 2.01e-03 | 720 | 67 | 10 | M41838 |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 2.03e-03 | 53 | 67 | 3 | M662 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.12e-03 | 191 | 67 | 5 | M29614 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 2.14e-03 | 54 | 67 | 3 | M27168 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 2.14e-03 | 54 | 67 | 3 | MM14871 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 2.14e-03 | 54 | 67 | 3 | M620 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.22e-03 | 193 | 67 | 5 | MM14890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 2.25e-03 | 15 | 67 | 2 | M47971 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 2.25e-03 | 15 | 67 | 2 | MM14536 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.31e-03 | 117 | 67 | 4 | MM15387 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | DNHD1 TRAPPC11 ERF WBP1L RANBP9 MCM4 CUBN AURKC ANAPC1 PREP TBC1D1 CATSPERG ANAPC5 ANAPC7 | 6.24e-09 | 670 | 98 | 14 | 22990118 |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 19826416 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 26115100 | ||
| Pubmed | Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. | 7.53e-07 | 7 | 98 | 3 | 9178903 | |
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 20686030 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 12470648 | ||
| Pubmed | Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons. | 2.57e-06 | 10 | 98 | 3 | 10500174 | |
| Pubmed | Characterization of the DOC1/APC10 subunit of the yeast and the human anaphase-promoting complex. | 2.57e-06 | 10 | 98 | 3 | 10318877 | |
| Pubmed | 3.52e-06 | 11 | 98 | 3 | 23604317 | ||
| Pubmed | Mitotic regulation of the human anaphase-promoting complex by phosphorylation. | 4.69e-06 | 12 | 98 | 3 | 14657031 | |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 16364912 | ||
| Pubmed | 6.08e-06 | 13 | 98 | 3 | 23979597 | ||
| Pubmed | 6.08e-06 | 13 | 98 | 3 | 16921029 | ||
| Pubmed | 7.72e-06 | 14 | 98 | 3 | 29183995 | ||
| Pubmed | Characterization of vertebrate cohesin complexes and their regulation in prophase. | 7.72e-06 | 14 | 98 | 3 | 11076961 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 32895527 | ||
| Pubmed | Localization and subcellular distribution of prolyl oligopeptidase in the mouse placenta. | 7.86e-06 | 2 | 98 | 2 | 21544597 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 9888854 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15384044 | ||
| Pubmed | Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. | 7.86e-06 | 2 | 98 | 2 | 16227599 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 16679292 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 16679293 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23221569 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 7657594 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 16239435 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23077605 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21109194 | ||
| Pubmed | PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. | 7.86e-06 | 2 | 98 | 2 | 12563258 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 16861917 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23063127 | ||
| Pubmed | Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors. | 7.86e-06 | 2 | 98 | 2 | 35395865 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 17164340 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18534979 | ||
| Pubmed | Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. | 7.86e-06 | 2 | 98 | 2 | 17071741 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 10459020 | ||
| Pubmed | Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. | 7.86e-06 | 2 | 98 | 2 | 15767666 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 7.86e-06 | 2 | 98 | 2 | 15388857 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 7643388 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 1314371 | ||
| Pubmed | 9.63e-06 | 15 | 98 | 3 | 10922056 | ||
| Pubmed | 9.63e-06 | 15 | 98 | 3 | 23007861 | ||
| Pubmed | 1.18e-05 | 16 | 98 | 3 | 10548110 | ||
| Pubmed | The anaphase-promoting complex: a key factor in the regulation of cell cycle. | 1.18e-05 | 16 | 98 | 3 | 15678131 | |
| Pubmed | 1.18e-05 | 16 | 98 | 3 | 25306923 | ||
| Pubmed | 1.43e-05 | 17 | 98 | 3 | 12070128 | ||
| Pubmed | 1.43e-05 | 17 | 98 | 3 | 23160376 | ||
| Pubmed | 1.43e-05 | 17 | 98 | 3 | 11340163 | ||
| Pubmed | TPR subunits of the anaphase-promoting complex mediate binding to the activator protein CDH1. | 1.43e-05 | 17 | 98 | 3 | 12956947 | |
| Pubmed | Atomic structure of the APC/C and its mechanism of protein ubiquitination. | 1.43e-05 | 17 | 98 | 3 | 26083744 | |
| Pubmed | Assembly and Function of Heterotypic Ubiquitin Chains in Cell-Cycle and Protein Quality Control. | 1.43e-05 | 17 | 98 | 3 | 29033132 | |
| Pubmed | 1.43e-05 | 17 | 98 | 3 | 21043528 | ||
| Pubmed | Mechanism of APC/CCDC20 activation by mitotic phosphorylation. | 1.43e-05 | 17 | 98 | 3 | 27114510 | |
| Pubmed | Recombinant expression, reconstitution and structure of human anaphase-promoting complex (APC/C). | 1.43e-05 | 17 | 98 | 3 | 23078409 | |
| Pubmed | BubR1 blocks substrate recruitment to the APC/C in a KEN-box-dependent manner. | 1.72e-05 | 18 | 98 | 3 | 22193957 | |
| Pubmed | Mitotic regulation of the APC activator proteins CDC20 and CDH1. | 1.72e-05 | 18 | 98 | 3 | 10793135 | |
| Pubmed | 1.72e-05 | 18 | 98 | 3 | 14593737 | ||
| Pubmed | 1.72e-05 | 18 | 98 | 3 | 11535616 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ERF NCKAP1 RANBP9 MCM4 PCARE AAR2 PTPN13 PTPRG PIK3R1 TBC1D1 MARF1 GID8 ZW10 ANAPC7 | 2.02e-05 | 1321 | 98 | 14 | 27173435 |
| Pubmed | Molecular mechanism of APC/C activation by mitotic phosphorylation. | 2.03e-05 | 19 | 98 | 3 | 27120157 | |
| Pubmed | Molecular architecture and mechanism of the anaphase-promoting complex. | 2.03e-05 | 19 | 98 | 3 | 25043029 | |
| Pubmed | 2.03e-05 | 19 | 98 | 3 | 25490258 | ||
| Pubmed | Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. | 2.35e-05 | 3 | 98 | 2 | 9888855 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 16006513 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 10627473 | ||
| Pubmed | RanBP9 controls the oligomeric state of CTLH complex assemblies. | 2.35e-05 | 3 | 98 | 2 | 36621627 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 12700661 | ||
| Pubmed | Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha. | 2.35e-05 | 3 | 98 | 2 | 15520044 | |
| Pubmed | Class 1A PI3K regulates vessel integrity during development and tumorigenesis. | 2.35e-05 | 3 | 98 | 2 | 18621722 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 12730242 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 20007249 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 17868034 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 19811262 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 18453570 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 17214991 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 21984976 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 7982920 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 30257216 | ||
| Pubmed | PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice. | 2.35e-05 | 3 | 98 | 2 | 16798720 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 15100712 | ||
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 22493067 | ||
| Pubmed | Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway. | 2.35e-05 | 3 | 98 | 2 | 19747165 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 19286672 | ||
| Pubmed | Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase. | 2.35e-05 | 3 | 98 | 2 | 17932028 | |
| Pubmed | p85 Associates with unphosphorylated PTEN and the PTEN-associated complex. | 2.35e-05 | 3 | 98 | 2 | 19635806 | |
| Pubmed | 2.35e-05 | 3 | 98 | 2 | 7509360 | ||
| Pubmed | 2.39e-05 | 20 | 98 | 3 | 11742988 | ||
| Pubmed | 2.39e-05 | 20 | 98 | 3 | 18162579 | ||
| Pubmed | 2.40e-05 | 59 | 98 | 4 | 15029244 | ||
| Pubmed | Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex. | 2.78e-05 | 21 | 98 | 3 | 18485873 | |
| Pubmed | NCKAP1 RANBP9 MCM4 AAR2 BAIAP2L1 ANAPC1 TIMELESS ANAPC5 ANAPC7 | 3.01e-05 | 560 | 98 | 9 | 35241646 | |
| Pubmed | NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons. | 3.21e-05 | 22 | 98 | 3 | 21946561 | |
| Pubmed | EG-1 interacts with c-Src and activates its signaling pathway. | 3.21e-05 | 22 | 98 | 3 | 16964398 | |
| Pubmed | 3.35e-05 | 129 | 98 | 5 | 23022380 | ||
| Pubmed | 3.96e-05 | 67 | 98 | 4 | 11285280 | ||
| Pubmed | 4.21e-05 | 24 | 98 | 3 | 33705438 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 10620012 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 24143168 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 9435577 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 7592789 | ||
| Pubmed | 4.70e-05 | 4 | 98 | 2 | 29567473 | ||
| Interaction | TLR8 interactions | 1.27e-05 | 10 | 97 | 3 | int:TLR8 | |
| Interaction | EPHA1 interactions | 1.80e-05 | 235 | 97 | 8 | int:EPHA1 | |
| Interaction | PPARD interactions | 2.16e-05 | 117 | 97 | 6 | int:PPARD | |
| Interaction | ROR1 interactions | 3.29e-05 | 126 | 97 | 6 | int:ROR1 | |
| Cytoband | 22q13.2 | 2.95e-04 | 60 | 98 | 3 | 22q13.2 | |
| GeneFamily | Anaphase promoting complex |Tetratricopeptide repeat domain containing | 1.43e-05 | 14 | 63 | 3 | 402 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.00e-05 | 115 | 63 | 5 | 769 | |
| GeneFamily | Glucosaminyl (N-acetyl) transferases/xylosyltransferases | 3.30e-04 | 8 | 63 | 2 | 441 | |
| GeneFamily | Septins | 9.09e-04 | 13 | 63 | 2 | 732 | |
| Coexpression | GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP | 8.74e-07 | 200 | 98 | 8 | M9522 | |
| Coexpression | HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY | 1.54e-06 | 23 | 98 | 4 | M1536 | |
| Coexpression | GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN | 1.04e-05 | 200 | 98 | 7 | M8302 | |
| Coexpression | WAESCH_ANAPHASE_PROMOTING_COMPLEX | 1.41e-05 | 13 | 98 | 3 | M7890 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 98 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 98 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 98 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 194 | 98 | 6 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.06e-06 | 198 | 98 | 6 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.91e-05 | 148 | 98 | 5 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney-Kidney_normal_tissue|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.95e-05 | 162 | 98 | 5 | a0367e9af78e4699b9d89d3e0597589e644f844c | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.95e-05 | 162 | 98 | 5 | d007ec42d6458431f6c490df61de7a9caef857f0 | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.95e-05 | 162 | 98 | 5 | 65549ffdbfe8619693345db78e6ddbdde7b742c9 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.22e-05 | 165 | 98 | 5 | 354978d4f35154d7b2e36e94de669e045adef512 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 166 | 98 | 5 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 169 | 98 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 174 | 98 | 5 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-05 | 178 | 98 | 5 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-05 | 178 | 98 | 5 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | severe-CD8+_T_naive|severe / disease stage, cell group and cell class | 4.87e-05 | 180 | 98 | 5 | 94fe530367b170777f4051a4034cff06d80dbb83 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 5.00e-05 | 181 | 98 | 5 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.13e-05 | 182 | 98 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 183 | 98 | 5 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 183 | 98 | 5 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 183 | 98 | 5 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.27e-05 | 183 | 98 | 5 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.55e-05 | 185 | 98 | 5 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| ToppCell | facs-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 189 | 98 | 5 | f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 189 | 98 | 5 | e3d65417997bdd3f9c312c0977dceb6eca061029 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 189 | 98 | 5 | 5559af03d9d612bb8dcf825e45744a9f8332bac8 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 6.30e-05 | 190 | 98 | 5 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 190 | 98 | 5 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 190 | 98 | 5 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 190 | 98 | 5 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.78e-05 | 193 | 98 | 5 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.95e-05 | 194 | 98 | 5 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.12e-05 | 195 | 98 | 5 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 195 | 98 | 5 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.29e-05 | 196 | 98 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-05 | 196 | 98 | 5 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-05 | 196 | 98 | 5 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-05 | 196 | 98 | 5 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.65e-05 | 198 | 98 | 5 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 7.65e-05 | 198 | 98 | 5 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-05 | 198 | 98 | 5 | e9e98c20ff7b3f3851db86381550ce7085e2db9e | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 7.65e-05 | 198 | 98 | 5 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 199 | 98 | 5 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 199 | 98 | 5 | e2d5c5cab102e67b0131b02392d81adaedc15965 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 199 | 98 | 5 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-05 | 199 | 98 | 5 | b768496381362f9a2706e0892b5a7a0db82e09ce | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.83e-05 | 199 | 98 | 5 | 97052c28e354833901f28d339b09f97f50a5b752 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 98 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | COVID-19-Fibroblasts-Vascular_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 8.02e-05 | 200 | 98 | 5 | c7f82196a0768ad96b1df8b8915bc541fb118a76 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-04 | 42 | 98 | 3 | b0ebd9d2456e4bab44e91b35d728224da6a052ea | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 121 | 98 | 4 | a5962d1c476e6966870832b72d511607e047248b | |
| ToppCell | VE-CD4-CD8_1|VE / Condition, Cell_class and T cell subcluster | 1.58e-04 | 123 | 98 | 4 | bc0f509716bb71d6e3fa343f4920ecb80eb62794 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-new-cluster|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 134 | 98 | 4 | dd0144af4f78d3483f129f908aadb1d67002aa9f | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 137 | 98 | 4 | e9b88ad86b75454a8292a94879c5b665adc42744 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.59e-04 | 140 | 98 | 4 | b9aeb7dda7f377b580dd8a44912f300721437387 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Tcf7l2_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.69e-04 | 57 | 98 | 3 | eab63d89e2100bb94fb026f700c2f82d657f92c1 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Tcf7l2_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.69e-04 | 57 | 98 | 3 | 2dc04513910af16d2cd84b3ae5b8d4c831124c68 | |
| ToppCell | TCGA-Breast-Metastatic-Breast_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.28e-04 | 149 | 98 | 4 | c7dc495141cd921b6b6f291a68851b7b807d0d0a | |
| ToppCell | TCGA-Breast-Metastatic-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.28e-04 | 149 | 98 | 4 | 2e9b898f3df22f8e872f2c278eff454c39e55b3b | |
| ToppCell | TCGA-Breast-Metastatic|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.28e-04 | 149 | 98 | 4 | 144ac2c458209ce510674bc2f83eb4c8e4d3c953 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.71e-04 | 154 | 98 | 4 | 0066b2b8cfc74603e97f271ef5efc7ec512110dc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 156 | 98 | 4 | ea9223bb6450b22df11efa1705ab72dab005244a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 156 | 98 | 4 | 586b5509074c4cc359e9e31a968c2ded71c994ca | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Trm_Th1/Th17|blood / Manually curated celltypes from each tissue | 3.99e-04 | 157 | 98 | 4 | c99cb26d831c25038f2aa1b1c0f7ba52facb2e7a | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.29e-04 | 160 | 98 | 4 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.39e-04 | 161 | 98 | 4 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-04 | 163 | 98 | 4 | 7af3d3ae7e0de733a18d0486c7ffbb5a7ef7230a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.60e-04 | 163 | 98 | 4 | ba7d02db0f0e2f9916ec8db52c067c87b6917c23 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-04 | 164 | 98 | 4 | df9fe446c1a43100048e11c01bf009bec3414dcf | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 4.71e-04 | 164 | 98 | 4 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-04 | 165 | 98 | 4 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 4.82e-04 | 165 | 98 | 4 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-04 | 165 | 98 | 4 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-04 | 166 | 98 | 4 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.93e-04 | 166 | 98 | 4 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.93e-04 | 166 | 98 | 4 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.93e-04 | 70 | 98 | 3 | 677deb7c7c100756a4cdc788d61feb45039a9a97 | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.04e-04 | 167 | 98 | 4 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.04e-04 | 167 | 98 | 4 | 3b717d33aaf1ef0869cc4bca8432ba8008875cc5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-04 | 167 | 98 | 4 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | Control-Lymphocytic_B-B_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-04 | 167 | 98 | 4 | a15a70d3837b31cc83a2a9e3f1bbfd77a95f2312 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-04 | 167 | 98 | 4 | 47447bcf184b1ad24ef17e135199fe7cd1d73c02 | |
| ToppCell | Control-Lymphocytic_B|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-04 | 167 | 98 | 4 | 956da82394fd6a9f45fc2031796f12cc889542cd | |
| ToppCell | Control-Lymphocytic_B-B_cells-B-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-04 | 167 | 98 | 4 | 69ed8a4a507190a1a66c4baf1f3e9be21ada39d8 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-04 | 167 | 98 | 4 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-04 | 168 | 98 | 4 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-04 | 168 | 98 | 4 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-04 | 168 | 98 | 4 | a4eebc78babb9b5ef33065b0642793820195a613 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-04 | 168 | 98 | 4 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.27e-04 | 169 | 98 | 4 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 169 | 98 | 4 | d6ad3b637de2935c656aad47ad82d6e8a8bd1227 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 169 | 98 | 4 | 0e3d0b71fc21fd1de7034d13895608de5494fad8 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 169 | 98 | 4 | 60ef186518d0dc63dbded2a77c65cfe3129df754 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 169 | 98 | 4 | c68a305069a149d66dfdeef2a8010f460dc1da3b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 169 | 98 | 4 | 149a4f83da15bdeb170e980fb5b5b1af89ae07a6 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 169 | 98 | 4 | 80089dfb1f0f4d6bdf6ca161e902b38011992dfd | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-04 | 170 | 98 | 4 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-04 | 170 | 98 | 4 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-04 | 170 | 98 | 4 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| Disease | X-linked agammaglobulinemia (implicated_via_orthology) | 1.07e-05 | 2 | 97 | 2 | DOID:14179 (implicated_via_orthology) | |
| Disease | myocardial infarction | 1.60e-04 | 350 | 97 | 7 | EFO_0000612 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 1.91e-04 | 34 | 97 | 3 | EFO_0009926 | |
| Disease | binge eating | 2.96e-04 | 8 | 97 | 2 | EFO_0005924 | |
| Disease | Agammaglobulinemia | 6.91e-04 | 12 | 97 | 2 | C0001768 | |
| Disease | colorectal cancer | 8.62e-04 | 604 | 97 | 8 | MONDO_0005575 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 9.49e-04 | 14 | 97 | 2 | cv:C2931907 | |
| Disease | sexual dimorphism measurement | DYM WBP1L APOB REST DYSF GCNT4 AAR2 TRANK1 PTPRG PIK3R1 EFR3B | 1.02e-03 | 1106 | 97 | 11 | EFO_0021796 |
| Disease | amenorrhea, response to antineoplastic agent | 1.09e-03 | 15 | 97 | 2 | EFO_0010269, GO_0097327 | |
| Disease | Manic | 2.19e-03 | 78 | 97 | 3 | C0338831 | |
| Disease | lung adenocarcinoma (is_marker_for) | 2.80e-03 | 85 | 97 | 3 | DOID:3910 (is_marker_for) | |
| Disease | lymphocyte count | ZNF217 REST GCNT2 GTF2IRD2B SEPTIN3 BAIAP2L1 ANAPC1 PIK3R1 TBC1D1 GTF2IRD2 STIP1 NSMAF | 3.07e-03 | 1464 | 97 | 12 | EFO_0004587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKNRYINILAYDHSR | 876 | P23470 | |
| LLMYQQHTSHYDLER | 611 | Q6ZRH7 | |
| KRYLQAHTQSVYNYH | 311 | P50548 | |
| AHLQHPNILRLYNYF | 96 | Q9UQB9 | |
| VNAYALNSIALHILY | 141 | Q8TDN7 | |
| YHQHNSAGLISRLKY | 361 | Q06187 | |
| FLVINYHQRVYHNRQ | 146 | P36896 | |
| TRYIHSLQHQQLLGY | 61 | Q8N7L0 | |
| HHTLYINLISILYHQ | 291 | Q9Y312 | |
| SRNHVHQLHTYYQLG | 1401 | Q9HAR2 | |
| YEYRLQHRTVAELNH | 2166 | Q96M86 | |
| KNEELRLYHHLFNNY | 21 | Q04844 | |
| SYYRDHNVELSKLLH | 841 | O95803 | |
| SYIGLSQNNLRVHYK | 176 | Q96S59 | |
| AEAHYLSYLNNLRVQ | 251 | Q9UJX4 | |
| QKYQLLVYHADSLFH | 41 | Q9UJX3 | |
| STDNRYHLQALRHLY | 1596 | Q9H1A4 | |
| RLAHHLVALYYQSEE | 661 | P33991 | |
| SKHLNRHLVNVYYLE | 1076 | Q13127 | |
| YQNRNYHLTPRTSLH | 366 | Q7Z353 | |
| AVLALTQNHHKQYYE | 491 | P19827 | |
| YVHQELLNHKNSYVI | 231 | Q8N0V5 | |
| NILHSEITNHIYYKT | 321 | Q5W064 | |
| ASLQELYLNHNQLYR | 141 | O75325 | |
| LYTLNKHQRFGYVQH | 241 | Q9BT17 | |
| HSQQLYRHIYLSCKE | 521 | Q9Y2G0 | |
| HIKVIQQYHLQYLAR | 421 | P55160 | |
| AVVLYLHNHSYASIQ | 571 | Q9UIQ6 | |
| DQRNTKLYQQLSHYH | 221 | Q9BYG7 | |
| NLYSSLKELVLHYQH | 686 | P27986 | |
| HITSNYLKQILNAAY | 511 | Q6XUX3 | |
| LLRNAYHAVYKQSVT | 1111 | Q9Y2A7 | |
| QYSHSIITNLLYHVV | 401 | P04062 | |
| NAYVTHLHAEYNRQK | 131 | O60906 | |
| HLHAEYNRQKDIYLA | 136 | O60906 | |
| ETSTNLHQKLYYHVL | 201 | P48147 | |
| LHQKLYYHVLGTDQS | 206 | P48147 | |
| LINHYRHESLAQYNA | 401 | O00459 | |
| YLLNLVATNAHLDHY | 211 | Q86WN1 | |
| DNALYFHLYSEHLRN | 561 | O60494 | |
| TLYALSHAVNNYHKT | 441 | P04114 | |
| VSYHGENLQHYILTL | 306 | Q9P2N4 | |
| HLHDRYGQLVNVYTK | 121 | O75146 | |
| NNESYHYARRQFHLT | 556 | Q04446 | |
| HIHYYHLQSAELLNS | 206 | Q9UHR4 | |
| VERLIHAIYNQHNIY | 146 | Q9P109 | |
| LLYTLLHQNSNIRTY | 351 | Q7RTS9 | |
| TDNQYHYFLRKLRIH | 1106 | Q5THR3 | |
| HLYTATARNSYHLQI | 41 | Q9GZV9 | |
| TNRYLYFHLQQQHLI | 96 | Q9NWU2 | |
| DIHHRILRYTNYQVA | 356 | Q674R7 | |
| AKNVRSLLHTYHYQQ | 1491 | Q9Y4F3 | |
| HDLFYHLELQVNRTY | 161 | Q8N6P7 | |
| QRGHLSNYQYLLHLN | 306 | Q92636 | |
| DKYLLHLNQNAYTTT | 486 | Q8N4M1 | |
| VSKEYNLRRHYQTNH | 456 | Q86UP8 | |
| VSKEYNLRRHYQTNH | 456 | Q6EKJ0 | |
| VQLIHYNHELYTNVT | 156 | Q9NS85 | |
| LETHLDKHNIYSIYN | 3171 | Q92736 | |
| LDQYLYQLRTHHLSQ | 736 | O75923 | |
| RTHHVQAESYLVYNI | 581 | Q96EK7 | |
| RVSYHRNIHYNSVVN | 326 | Q96G74 | |
| QHTLTCHQYYLQLRK | 671 | Q12923 | |
| VKAHQQAYTYLHSSL | 181 | A6NGG8 | |
| ALIHGLNRHYYSITI | 191 | O00487 | |
| TDYKSYELISQLHQH | 121 | Q9BPW5 | |
| IGNHRMYQNYLRNHL | 161 | P59551 | |
| TLLKNYSYNEIHNRR | 106 | P84550 | |
| SYHLQQSQHQKVREY | 81 | P19484 | |
| HNHVLYSNRSAAYAK | 36 | P31948 | |
| KLNHIYQFEYVSQHL | 586 | Q9ULQ0 | |
| THHTLQQYLYKPRQE | 616 | P48764 | |
| VYYLHQNNIVHLDLK | 146 | O94768 | |
| SEKQQASHYLYVRAH | 31 | Q9Y3A4 | |
| HYKEYLVSLINAHSL | 1001 | Q96EP0 | |
| FRHHFLQVLTYLQAY | 106 | Q9UNS1 | |
| AYVLLLRSYQQNSAH | 706 | Q9UNS1 | |
| LSHNNIYTLTDKYNL | 591 | Q9NR97 | |
| NYRTAYNLVHELRAH | 246 | Q7Z392 | |
| YYQRALQLHPQHNRA | 536 | Q8IUR5 | |
| YHNYRQEDLLDSLIH | 196 | Q6ZVK1 | |
| ADLLQYNRAQVLYHA | 281 | Q6NXR4 | |
| YNRAQVLYHAISNHL | 286 | Q6NXR4 | |
| THNIHYETYRAKRLN | 316 | Q9UH03 | |
| SRAHLLLTDYNYVVQ | 206 | Q9NV64 | |
| QMYQLSRLLHDYHRD | 936 | Q86TI0 | |
| ITHNIHYENYRVIRL | 301 | Q8IYM1 | |
| HYENYRVIRLNESHL | 306 | Q8IYM1 | |
| YRYSSQLIQHQRKHN | 311 | Q6AZW8 | |
| LHLNRATLHKYEESY | 226 | Q8N0Z6 | |
| SYIAHLRQILANDKY | 126 | O43680 | |
| AHVYYQRLSDELKQH | 111 | A1L157 | |
| NYLSELHEHLKYDQL | 171 | P85298 | |
| YFSQNRQLKSHYRVH | 386 | O43167 | |
| RSNYYLNIHLRTHTG | 481 | O75362 | |
| QIQFPLYTAYKHNTH | 166 | Q70CQ2 | |
| IHQLYQNYRSHSGIL | 1461 | O15050 | |
| VNGHLYKTNYLTHRQ | 211 | P17948 | |
| QHEINLIAYREAHNY | 76 | Q9NX94 | |
| TYVQSLYNHLRRHEL | 896 | P53814 | |
| YLQTELHLYTEQSHK | 201 | O43264 | |
| KIRYLQEYHNRVLHN | 11 | Q9P2D8 | |
| VLHNSYALHGIRYKN | 476 | Q8IYS2 | |
| DRALHAYKLQSSNLY | 4936 | P20929 |